The Ophthalmology Times Group talked to an optometrist practice about their experience with ocular nutraceuticals
EssilorLuxottica announces agreement for acquisition of Espansione Group
Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
European Medicines Agency approves faricimab (Vabysmo) 6.0 mg single-dose prefilled syringe
The PFS is approved for treatment of neovascular age-related macular degeneration, diabetic macular oedema and macular oedema following retinal vein occlusion
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Diabetic eye disease: Where are we now?
Clinicians must consider redefining the metrics and intention behind functional outcomes, according to experts from the European Association for the Study of Diabetic Eye Complications
Case report: retinopathy associated with the use of hair dye aromatic amines
Presentation closely resembled mitogen-activated extracellular signal-regulated kinase inhibitor–associated retinopathy